Literature DB >> 9720853

The nature of fatigue in multiple sclerosis.

H Ford1, P Trigwell, M Johnson.   

Abstract

The aim of this cross-sectional descriptive study was to determine whether people with multiple sclerosis differentially experience physical and mental fatigue, and whether the pattern of fatigue is influenced by mood, disease duration, or disease course. Seventy-eight consecutive out-patients with multiple sclerosis were asked to complete the Fatigue Rating Scale (FRS) and the Hospital Anxiety and Depression Scale (HAD). Sixty-eight (87%) subjects completed the questionnaires. Fifty-eight (85%) subjects in this group scored above the recommended cut-off for fatigue on the FRS scale. Both the mental fatigue score and the total fatigue score were positively correlated with the depression and anxiety scores on the HAD scale. There was no significant correlation between the physical fatigue score and either of the HAD subscale scores. There was no significant association between duration of disease or disease course and the total scores or subscale scores of the FRS and HAD. This is the first reported study to differentiate between mental and physical fatigue in multiple sclerosis and to demonstrate a significant correlation between fatigue and mood level. This has important implications for the effective treatment of fatigue in multiple sclerosis.

Entities:  

Mesh:

Year:  1998        PMID: 9720853     DOI: 10.1016/s0022-3999(98)00004-x

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  29 in total

Review 1.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

3.  Anxiety Modifies the Association between Fatigue and Verbal Fluency in Cognitively Normal Adults.

Authors:  Deirdre M O'Shea; Liselotte De Wit; Sarah M Szymkowicz; Molly E McLaren; Francis Talty; Vonetta M Dotson
Journal:  Arch Clin Neuropsychol       Date:  2016-12-01       Impact factor: 2.813

4.  Postural response latencies are related to balance control during standing and walking in patients with multiple sclerosis.

Authors:  Jessie M Huisinga; Rebecca J St George; Rebecca Spain; Shannon Overs; Fay B Horak
Journal:  Arch Phys Med Rehabil       Date:  2014-01-18       Impact factor: 3.966

5.  Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.

Authors:  J S Kalkman; M L Schillings; S P van der Werf; G W Padberg; M J Zwarts; B G M van Engelen; G Bleijenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

Review 6.  Depression in multiple sclerosis: a review.

Authors:  R J Siegert; D A Abernethy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

7.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

8.  Validation of the Fatigue Impact Scale in Hungarian patients with multiple sclerosis.

Authors:  Erika Losonczi; Krisztina Bencsik; Cecília Rajda; Gyula Lencsés; Margit Török; László Vécsei
Journal:  Qual Life Res       Date:  2010-09-24       Impact factor: 4.147

9.  Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals.

Authors:  Tanja Grubić Kezele; Matea Babić; Dinko Štimac
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

Review 10.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

Authors:  Stefan M Gold; Michael R Irwin
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.